Hypoxia-induced upregulation of SNAF2 (or SLC38A2) expression via HIF-1α increases Gln uptake, resulting in complete resistance of BC cells to estrogen and certain VEGF therapies [105]. Here, SLC38A2 is linked to breast cancer.